Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=99"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=99

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00141102-3926df21",
        "title": "Celecoxib vs Oral Diclofenac Plus Omeprazole: Number of Subjects With SUs",
        "summary": "5 of 2238 against 11 of 2246; risk difference -0.3 points, 95% interval -0.7 to 0.1; NCT00141102, Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis",
        "record": "/library/comparisons/NCT00141102-3926df21",
        "nct_id": "NCT00141102",
        "kind": "outcome",
        "participants": 4484,
        "risk_difference": {
          "value": -0.00266345810285707,
          "lower": -0.006721778351325638,
          "upper": 0.001021741198921569
        },
        "group_1": "5 of 2,238",
        "group_2": "11 of 2,246",
        "difference": "-0.3 points",
        "interval": "-0.7 to 0.1",
        "trial_title": "Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis"
      },
      {
        "id": "NCT00141102-46da923d",
        "title": "Celecoxib vs Oral Diclofenac Plus Omeprazole: Number of Subjects With CSULGIES or Symptomatic Ulcers (SUs)",
        "summary": "25 of 2238 against 92 of 2246; risk difference -3.0 points, 95% interval -3.9 to -2.1; NCT00141102, Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis",
        "record": "/library/comparisons/NCT00141102-46da923d",
        "nct_id": "NCT00141102",
        "kind": "outcome",
        "participants": 4484,
        "risk_difference": {
          "value": -0.02979102159175641,
          "lower": -0.039491980975307844,
          "upper": -0.020671851264973524
        },
        "group_1": "25 of 2,238",
        "group_2": "92 of 2,246",
        "difference": "-3.0 points",
        "interval": "-3.9 to -2.1",
        "trial_title": "Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=100",
  "request_id": "uYuXNJbS15SpLcVN"
}